Public perspective on potential treatment intervention harm in clinical trials-terminology and communication

Phillips, RachelBi, DongquanGoulão, BeatrizMiller, MarieEl-Askary, MalakFagbemi, OluyemiFreeborn, CurieGiammetta, MariaEl Masri, NouraFlockhart, PeterKumar, ManosMelvin, MikeMurray, DianneMyhill, AnthonySaeid, LailaThomas, ShaniceMacLennan, GraemeCornelius, Victoria2024-09-022024-09-022024-08-31Phillips, R, Bi, D, Goulão, B, Miller, M, El-Askary, M, Fagbemi, O, Freeborn, C, Giammetta, M, El Masri, N, Flockhart, P, Kumar, M, Melvin, M, Murray, D, Myhill, A, Saeid, L, Thomas, S, MacLennan, G & Cornelius, V 2024, 'Public perspective on potential treatment intervention harm in clinical trials-terminology and communication', Trials, vol. 25, no. 1, 573. https://doi.org/10.1186/s13063-024-08418-w1745-6215PubMedCentral: PMC11365119ORCID: /0000-0002-1039-5646/work/166662862https://hdl.handle.net/2164/2414791174879engClinical trialsAdverse eventsHarmsPublic partnersPatient and public involvementR MedicineNational Institute for Health Research (NIHR)NIHR152365NIHR 22/17RPublic perspective on potential treatment intervention harm in clinical trials-terminology and communicationJournal article10.1186/s13063-024-08418-w251